1. Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29(13):1583–1590. doi: 10.1002/mds.25945
2. Mohanakumar KP, Chandra G, Haobam R, Selley ML (2009) Treatment of brain disorders. US20090143388 A1,
3. Bergmann JE, Cutshall NS, Demopulos GA, Florio VA, Gaitanaris GA, Gray P, Hohmann J, Onrust R, Zeng H (2011) Use of PDE7 inhibitors for the treatment of movement disorders. Google Patents
4. Gil AM, Ayuso-Gontan CG, Martín CP, Castillo AP, García JM, Redondo M, Cristóbal MSS (2012) Use of quinazoline derivatives for neurodegenerative diseases. Google Patents,
5. Kelly PJ, Ahlskog JE, Goerss SJ, Daube JR, Duffy JR, Kall BA (1987) Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson’s disease. Mayo Clin Proc 62(8):655–664